Utah Medical Products, Inc. (UTMD) Financial Statements
Utah Medical Products, Inc. (UTMD) reported trailing twelve-month revenue of $36.1M (down 7.0% year on year) and net income of $10.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $11.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 236.3M
- P/E TTM
- 22.6
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26. Results for the next quarter were released 22 Oct; these figures move once the 10-Q is filed.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.9 | 41.6 | 40.5 | 41.3 | 40.2 | 39.3 | 41.4 | 42.0 | 46.9 | 42.2 | 49.1 | 52.3 | 50.2 | 40.9 | 38.5 | 36.1 | |
| Gross profit | 22.4 | 25.3 | 24.3 | 25.0 | 24.2 | 23.7 | 26.4 | 26.3 | 29.5 | 25.5 | 30.9 | 32.2 | 30.0 | 24.1 | 22.0 | 20.9 | |
| Research & development | -0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.8 | 0.7 | 0.7 | |
| Operating income | 11.8 | 15.2 | 14.8 | 16.2 | 15.7 | 16.2 | 19.0 | 18.7 | 17.6 | 13.7 | 18.9 | 19.8 | 16.8 | 13.6 | 11.4 | 10.3 | |
| Pre-tax income | 11.1 | 14.5 | 14.5 | 15.8 | 15.5 | 16.4 | 19.1 | 19.5 | 17.9 | 13.8 | 19.1 | 20.7 | 20.1 | 16.8 | 14.1 | 12.9 | |
| Income tax | 3.7 | 4.4 | 3.1 | 4.4 | 3.7 | 4.3 | 10.6 | 0.9 | 3.2 | 3.0 | 4.3 | 4.2 | 3.5 | 2.9 | 2.8 | 2.4 | |
| Net income | 7.4 | 10.2 | 11.4 | 11.4 | 11.8 | 12.1 | 8.5 | 18.6 | 14.7 | 10.8 | 14.8 | 16.5 | 16.6 | 13.9 | 11.3 | 10.5 | |
| Diluted EPS ($) | 2.03 | 2.74 | 3.02 | 3.02 | 3.14 | 3.22 | 2.28 | 4.95 | 3.94 | 2.94 | 4.04 | 4.52 | 4.57 | 3.96 | 3.48 | 3.28 | |
| Diluted shares (mn) | — | 3.7 | 3.8 | 3.8 | 3.8 | 3.8 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 | 3.6 | 3.6 | 3.5 | 3.2 | — |
USD millions · SEC XBRL
Utah Medical Products, Inc. — questions
- What is Utah Medical Products, Inc.'s revenue?
- $36.1M over the twelve months to 2026-06-30, down 7.0% year on year, from its 10-Q and 10-K filings.
- What is Utah Medical Products, Inc.'s net income?
- $10.5M over the twelve months to 2026-06-30.
- What is Utah Medical Products, Inc.'s free cash flow?
- $11.4M over the twelve months to 2026-06-30.
- What are Utah Medical Products, Inc.'s diluted earnings per share?
- $3.28 over the twelve months to 2026-06-30.
Every figure on this page comes from Utah Medical Products, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.